Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity

NeuroImage

Volumn 122, Issue , 2015, Pages 440-450

  Klaassens, Bernadet L ^a,b,c   van Gorsel, Helene C ^c   Khalili Mahani, Najmeh ^d   van der Grond, Jeroen ^b   Wyman, Bradley T ^e   Whitcher, Brandon ^e   Rombouts, Serge A R B ^a,b   van Gerven, Joop M A ^c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^d MCGILL UNIVERSITY   (Canada)

^e PFIZER INC   (United States)

Author keywords

FMRI; Functional connectivity; Neuropharmacology; Resting state networks; Serotonin; SSRI

Indexed keywords

DRUG METABOLITE; GRANISETRON; HYDROCORTISONE; NORSERTRALINE; PLACEBO; PROLACTIN; SEROTONIN; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; AUDITORY NETWORK; BREATHING; CEREBROSPINAL FLUID; CONNECTOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFAULT MODE NETWORK; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPHARMACOLOGY; NORMAL HUMAN; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTING STATE NETWORK; SENSORIMOTOR NETWORK; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION; VISUAL NETWORK; VOXEL BASED MORPHOMETRY; WHITE MATTER; BLOOD; BRAIN; BRAIN MAPPING; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; YOUNG ADULT;

ADULT; BRAIN; BRAIN MAPPING; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; YOUNG ADULT;

EID: 84943566419     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.08.012     Document Type: Article

References (110)

1. Adell A., Celada P., Abellan M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Rev. 2002, 39(2-3):154-180.
2. Amargos-Bosch M., Bortolozzi A., Puig M.V., Serrats J., Adell A., Celada P., Toth M., Mengod G., Artigas F. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 2004, 14(3):281-299.
3. Anand A., Li Y., Wang Y., Wu J.W., Gao S.J., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol. Psychiatry 2005, 57(10):1079-1088.
4. Anderson I.M., Del-Ben C.M., Mckie S., Richardson P., Williams S.R., Elliott R., Deakin J.F.W. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport 2007, 18(13):1351-1355.
5. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38(8):1083-1152.
6. Beckmann C.F., Mackay C.E., Filippini N., Smith S.M. Group Comparison of Resting-state FMRI Data Using Multi-subject ICA and Dual Regression 2009, OHBM.
7. Bhagwagar Z., Cowen P.J., Goodwin G.M., Harmer C.J. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am. J. Psychiatry 2004, 161(1):166-168.
8. Birn R.M. The role of physiological noise in resting-state functional connectivity. NeuroImage 2012, 62(2):864-870.
9. Bond A., Lader M. Use of analog scales in rating subjective feelings. Br. J. Med. Psychol. 1974, 47(3):211-218.
10. Borland R.G., Nicholson A.N. Visual motor coordination and dynamic visual-acuity. Br. J. Clin. Pharmacol. 1984, 18(Suppl. 1):S69-S72.
11. Briley M., Moret C. Neurobiological mechanisms involved in antidepressant therapies. Clin. Neuropharmacol. 1993, 16(5):387-400.
12. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. J. Psychopharmacol. 2007, 21(7):684-690.
13. Bruhl A.B., Kaffenberger T., Herwig U. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology 2010, 35(2):521-533.
14. Bruhl A.B., Jancke L., Herwig U. Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology 2011, 216(3):389-399.
15. Burton H., Wineland A., Bhattacharya M., Nicklaus J., Garcia K.S., Piccirillo J.F. Altered networks in bothersome tinnitus: a functional connectivity study. BMC Neurosci. 2012, 13(3).
16. Carr G.V., Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology 2011, 213(2-3):265-287.
17. Carrasco J.L., Sandner C. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. Int. J. Clin. Pract. 2005, 59(12):1428-1434.
18. Cavanna A.E., Trimble M.R. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006, 129:564-583.
19. Celada P., Puig M.V., Artigas F. Serotonin modulation of cortical neurons and networks. Front. Integr. Neurosci. 2013, 7(25).
20. Cole D.M., Beckmann C.F., Oei N.Y.L., Both S., van Gerven J.M.A., Rombouts S.A.R.B. Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity. NeuroImage 2013, 78:59-67.
21. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010, 33(9):424-434.
22. Del-Ben C.M., Deakin J.F.W., Mckie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 2005, 30(9):1724-1734.
23. Dumont G.J.H., de Visser S.J., Cohen A.F., van Gerven J.M.A. Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br. J. Clin. Pharmacol. 2005, 59(5):495-510.
24. Feczko E., Miezin F.M., Constantino J.N., Schlaggar B.L., Petersen S.E., Pruett J.R. The hemodynamic response in children with simplex autism. Dev. Cogn. Neurosci. 2012, 2(4):396-408.
25. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-epsilon 4 allele. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(17):7209-7214.
26. Fox M.D., Raichle M.E. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat. Rev. Neurosci. 2007, 8(9):700-711.
27. Fransson P., Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis. NeuroImage 2008, 42(3):1178-1184.
28. Frazer A., Benmansour S. Delayed pharmacological effects of antidepressants. Mol. Psychiatry 2002, 7(Suppl. 1):S23-S28.
29. Geday J., Hermansen F., Rosenberg R., Smith D.F. Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans. Synapse 2005, 55(4):224-229.
30. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry 2007, 62(5):429-437.
31. Greve D.N., Fischl B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage 2009, 48(1):63-72.
32. Hamilton J.P., Furman D.J., Chang C., Thomason M.E., Dennis E., Gotlib I.H. Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol. Psychiatry 2011, 70(4):327-333.
33. Harmer C.J. Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 2008, 55(6):1023-1028.
34. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003, 28(1):148-152.
35. Harmer C.J., Hill S.A., Taylor M.J., Cowen P.J., Goodwin G.M. Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am. J. Psychiatry 2003, 160(5):990-992.
36. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br. J. Psychiatry 2009, 195(2):102-108.
37. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 2006, 30(2):203-214.
38. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71(4):533-554.
39. Jacobs B.L., Azmitia E.C. Structure and function of the brain-serotonin system. Physiol. Rev. 1992, 72(1):165-229.
40. Jacobs B.L., Fornal C.A. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999, 21(Suppl. 2):S9-S15.
41. Jacobs G.E., Kamerling I.M.C., de Kam M.L., DeRijk R.H., van Pelt J., Zitman F.G., van Gerven J.M.A. Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron. J. Psychopharmacol. 2010, 24(1):65-72.
42. Jacobs G.E., van der Grond J., Teeuwisse W.M., Langeveld T.J.C., van Pelt J., Verhagen J.C.M., de Kam M.L., Cohen A.F., Zitman F.G., van Gerven J.M.A. Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 34(3):486-491.
43. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. FSL. NeuroImage 2012, 62:782-790.
44. Joseph R. The limbic system - emotion, laterality, and unconscious mind. Psychoanal. Rev. 1992, 79(3):405-456.
45. Kahkonen S., Ahveninen J., Pennanen S., Liesivuori J., Ilmoniemi R.J., Jaaskelainen I.P. Serotonin modulates early cortical auditory processing in healthy subjects. Evidence from MEG with acute tryptophan depletion. Neuropsychopharmacology 2002, 27(5):862-868.
46. Khalili-Mahani N., Zoethout R.M.W., Beckmann C.F., Baerends E., de Kam M.L., Soeter R.P., Dahan A., van Buchem M.A., van Gerven J.M.A., Rombouts S.A.R.B. Effects of morphine and alcohol on functional brain connectivity during "resting state": a placebo-controlled crossover study in healthy young men. Hum. Brain Mapp. 2012, 33(5):1003-1018.
47. Khalili-Mahani N., Chang C., van Osch M.J., Veer I.M., van Buchem M.A., Dahan A., Beckmann C.F., van Gerven J.M.A., Rombouts S.A.R.B. The impact of "physiological correction" on functional connectivity analysis of pharmacological resting state fMRI. NeuroImage 2013, 65:499-510.
48. Khalili-Mahani N., Niesters M., van Osch M.J., Oitzl M., Veer I., de Rooij M., van Gerveng J., van Buchem M.A., Beckmann C.F., Rombouts S.A.R.B., Dahan A. Ketamine interactions with biomarkers of stress: a randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men. NeuroImage 2015, 108:396-409.
49. Kim J.Y., Kim Y.H., Lee S., Seo J.H., Song H.J., Cho J.H., Chang Y. Alteration of functional connectivity in tinnitus brain revealed by resting-state fMRI?: a pilot study. Int. J. Audiol. 2012, 51(5):413-417.
50. Klomp A., Caan M.W.A., Denys D., Nederveen A.J., Reneman L. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function. NeuroImage 2012, 63(3):1695-1700.
51. Klumpers L.E., Cole D.M., Khalili-Mahani N., Soeter R.P., te Beek E.T., Rombouts S.A.R.B., van Gerven J.M.A. Manipulating brain connectivity with delta(9)-tetrahydrocannabinol: a pharmacological resting state FMRI study. NeuroImage 2012, 63(3):1701-1711.
52. Kraus C., Ganger S., Losak J., Hahn A., Savli M., Kranz G.S., Baldinger P., Windischberger C., Kasper S., Lanzenberger R. Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake. NeuroImage 2014, 84:236-244.
53. Laeng B., Lag T., Brennen T. Reduced stroop interference for opponent colors may be due to input factors: evidence from individual differences and a neural network simulation. J. Exp. Psychol. Hum. Percept. Perform. 2005, 31(3):438-452.
54. Lezak M.D. Neuropsychological Assessment 2004, Oxford University Press, New York.
55. Li B.J., Liu L., Friston K.J., Shen H., Wang L.B., Zeng L.L., Hu D.W. A treatment-resistant default mode subnetwork in major depression. Biol. Psychiatry 2013, 74(1):48-54.
56. Lidow M.S., Goldmanrakic P.S., Gallager D.W., Geschwind D.H., Rakic P. Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus-monkey. Neuroscience 1989, 32(3):609-627.
57. Lidow M.S., Goldmanrakic P.S., Gallager D.W., Rakic P. Quantitative autoradiographic mapping of serotonin 5-Ht1 and 5-Ht2 receptors and uptake sites in the neocortex of the rhesus-monkey. J. Comp. Neurol. 1989, 280(1):27-42.
58. Lim H.K., Juh R., Pae C.U., Lee B.T., Yoo S.S., Ryu S.H., Kwak K.R., Lee C., Lee C.U. Altered verbal working memory process in patients with Alzheimer's disease. Neuropsychobiology 2008, 57(4):181-187.
59. Loubinoux I., Pariente J., Boulanouar K., Carel C., Manelfe C., Rascol O., Celsis P., Chollet F. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. NeuroImage 2002, 15(1):26-36.
60. Loubinoux I., Pariente J., Rascol O., Celsis P., Chollet F. Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects. Neuropsychologia 2002, 40(11):1815-1821.
61. Lu H., Stein E.A. Resting state functional connectivity: its physiological basis and application in neuropharmacology. Neuropharmacology 2014, 84:79-89.
62. Maudoux A., Lefebvre P., Cabay J.E., Demertzi A., Vanhaudenhuyse A., Laureys S., Soddu A. Auditory resting-state network connectivity in tinnitus: a functional MRI study. PLoS One 2012, 7(5):e36222.
63. Maudoux A., Lefebvre P., Cabay J.E., Demertzi A., Vanhaudenhuyse A., Laureys S., Soddu A. Connectivity graph analysis of the auditory resting state network in tinnitus. Brain Res. 2012, 1485:10-21.
64. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatr. Clin. Neurosci. 1997, 9(3):471-481.
65. McCabe C., Mishor Z. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. NeuroImage 2011, 57(4):1317-1323.
66. McCabe C., Mishor Z., Filippini N., Cowen P.J., Taylor M.J., Harmer C.J. SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex. Mol. Psychiatry 2011, 16(6):592-594.
67. McKie S., Del-Ben C., Elliott R., Williams S., del Vai N., Anderson I., Deakin J.F.W. Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology 2005, 180(4):680-686.
68. McRae A., McRae K., Brady Review of sertraline and its clinical applications in psychiatric disorders. Expert. Opin. Pharmacother. 2001, 2(5):883-892.
69. Morgane P.J., Galler J.R., Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog. Neurobiol. 2005, 75(2):143-160.
70. Morrison J.H., Foote S.L., Molliver M.E., Bloom F.E., Lidov H.G. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. Proc. Natl. Acad. Sci. U. S. A. 1982, 79(7):2401-2405.
71. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. Br. J. Psychiatry 2009, 194(6):535-540.
72. Nichols D.E., Nichols C.D. Serotonin receptors. Chem. Rev. 2008, 108(5):1614-1641.
73. Niesters M., Khalili-Mahani N., Martini C., Aarts L., van Gerven J., van Buchem M.A., Dahan A., Rombouts S. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers. Anesthesiology 2012, 117(4):868-877.
74. Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 1971, 10(21):181-191.
75. Oliveri M., Calvo G. Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study. J. Neurol. Neurosurg. Psychiatry 2003, 74(8):1136-1138.
76. Outhred T., Hawkshead B.E., Wager T.D., Das P., Malhi G.S., Kemp A.H. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: implications for differential treatment efficacy. Neurosci. Biobehav. Rev. 2013, 37(8):1786-1800.
77. Peroutka S.J., Snyder S.H. Multiple serotonin receptors - differential binding of [5-hydroxytryptamine-H-3, [lysergic-H-3 acid diethylamide and [H-3]spiroperidol. Mol. Pharmacol. 1979, 16(3):687-699.
78. Rack-Gomer A.L., Liu T.T. Caffeine increases the temporal variability of resting-state BOLD connectivity in the motor cortex. NeuroImage 2012, 59(3):2994-3002.
79. Rack-Gomer A.L., Liau J., Liu T.T. Caffeine reduces resting-state BOLD functional connectivity in the motor cortex. NeuroImage 2009, 46(1):56-63.
80. Reynell C., Harris J.J. The BOLD signal and neurovascular coupling in autism. Dev. Cogn. Neurosci. 2013, 6:72-79.
81. Rijnbeek B., De Visser S., Franson K., Cohen A., Van Gerven J. REM sleep reduction as a biomarker for the effects of antidepressants in healthy volunteers. Br. J. Clin. Pharmacol. 2002, 54(5):561-562.
82. Robinson S. Antidepressants for treatment of tinnitus. Prog. Brain Res. 2007, 166:263-271.
83. Rogers M.A., Kasai K., Koji M., Fukuda R., Iwanami A., Nakagome K., Fukuda M., Kato N. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci. Res. 2004, 50(1):1-11.
84. Sagud M., Pivac N., Muck-Seler D., Jakovljevic M., Mihaljevic-Peles A., Korsic M. Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 2002, 45(3):139-143.
85. Schaefer A., Burmann I., Regenthal R., Arelin K., Barth C., Pampel A., Villringer A., Margulies D.S., Sacher J. Serotonergic modulation of intrinsic functional connectivity. Curr. Biol. 2014, 24(19):2314-2318.
86. Seminowicz D.A., Mayberg H.S., McIntosh A.R., Goldapple K., Kennedy S., Segal Z., Rafi-Tari S. Limbic-frontal circuitry in major depression: a path modeling metanalysis. NeuroImage 2004, 22(1):409-418.
87. Sheline Y.I., Price J.L., Yan Z.Z., Mintun M.A. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(24):11020-11025.
88. Shima K., Tanji J. Role for cingulate motor area cells in voluntary movement selection based on reward. Science 1998, 282(5392):1335-1338.
89. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17(3):143-155.
90. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009, 44(1):83-98.
91. Smith G.S., Ma Y., Dhawan V., Gunduz H., Carbon M., Kirshner M., Larson J., Chaly T., Belakhleff A., Kramer E., Greenwald B., Kant J.M., Laghrissi-Thode F., Pollock B.G., Eidelber D. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 2002, 45(2):105-112.
92. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y.Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23(Suppl. 1):S208-S219.
93. Smith S.M., Fox P.T., Miller K.L., Glahn D.C., Fox P.M., Mackay C.E., Filippini N., Watkins K.E., Toro R., Laird A.R., Beckmann C.F. Correspondence of the brain's functional architecture during activation and rest. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(31):13040-13045.
94. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 1935, 18:643-662.
95. Sundermann B., Beverborg M.O.L., Pfleiderer B. Toward literature-based feature selection for diagnostic classification: a meta-analysis of resting-state fMRI in depression. Front. Hum. Neurosci. 2014, 692(8).
96. Thompson G.C., Thompson A.M., Garrett K.M., Britton B.H. Serotonin and serotonin receptors in the central auditory-system. Otolaryngol. Head Neck Surg. 1994, 110(1):93-102.
97. Ueyama T., Donishi T., Ukai S., Ikeda Y., Hotomi M., Yamanaka N., Shinosaki K., Terada M., Kaneoke Y. Brain regions responsible for tinnitus distress and loudness: a resting-state fMRI study. PLoS One 2013, 8(6):e67778.
98. van de Ven V., Wingen M., Kuypers K.P.C., Ramaekers J.G., Formisano E. Escitalopram decreases cross-regional functional connectivity within the default-mode network. PLoS One 2013, 8(6):e68355.
99. van Wingen G.A., Tendolkar I., Urner M., van Marle H.J., Denys D., Verkes R.J., Fernandez G. Short-term antidepressant administration reduces default mode and task-positive network connectivity in healthy individuals during rest. NeuroImage 2014, 88:47-53.
100. Veer I.M., Oei N.Y.L., Spinhoven P., van Buchem M.A., Elzinga B.M., Rombouts S.A.R.B. Endogenous cortisol is associated with functional connectivity between the amygdala and medial prefrontal cortex. Psychoneuroendocrinology 2012, 37(7):1039-1047.
101. Viviani R., Abler B., Seeringer A., Stingl J.C. Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study. NeuroImage 2012, 61(4):773-779.
102. Vogt B.A., Finch D.M., Olson C.R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb. Cortex 1992, 2(6):435-443.
103. von Bardeleben U., Steiger A., Gerken A., Holsboer F. Effects of Fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. Int. Clin. Psychopharmacol. 1989, 4:1-5.
104. Wechsler D. The psychometric tradition - developing the Wechsler Adult Intelligence Scale. Contemp. Educ. Psychol. 1981, 6(2):82-85.
105. Whale R., Clifford E.M., Bhagwagar Z., Cowen P.J. Decreased sensitivity of 5-HT1D receptors in melancholic depression. Br. J. Psychiatry 2001, 178:454-457.
106. Winkler A.M., Ridgway G.R., Webster M.A., Smith S.M., Nichols T.E. Permutation inference for the general linear model. NeuroImage 2014, 92:381-397.
107. Wong C.W., Olafsson V., Tal O., Liu T.T. Anti-correlated networks, global signal regression, and the effects of caffeine in resting-state functional MRI. NeuroImage 2012, 63(1):356-364.
108. Woolrich M.W., Jbabdi S., Patenaude B., Chappell M., Makni S., Behrens T., Beckmann C., Jenkinson M., Smith S.M. Bayesian analysis of neuroimaging data in FSL. NeuroImage 2009, 45(Suppl. 1):S173-S186.
109. Zhang S., Li C.S.R. Functional connectivity mapping of the human precuneus by resting state fMRI. NeuroImage 2012, 59(4):3548-3562.
110. Zhu X.L., Wang X., Xiao J., Liao J., Zhong M.T., Wang W., Yao S.Q. Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol. Psychiatry 2012, 71(7):611-617.